SIP 2017 Presentation
Maurizio Cutolo – EULAR, Switzerland
"Almost all Rheumatic and Muskuloskeletal Diseases (RMD) are characterized by the presence of acute/ chronic pain. Pain is an early symptom that Signals an inflammatory/ degenerative condition. Early correct diagnosis and Treatment of any pathological condition is followed by the disappearance of the pain."
Professor Maurizio Cutolo MD, FA CR
Chronic pain in Rheumatic and Muskuloskeletal Diseases (RMD) is characterized by a circadian rhythm and in cases of Long term persistency, pain causes severe depression and social discomfort for the patient affected. Pain is an early symptom that signals a pathological inflammatory condition and early correct diagnosis and treatment of the causes is followed by the decrease/disappearance of the pain. Treatment of pain without temptatives to remove the causes is unsuccessful. Prof. M Cutolo and his TEAM studies the neuroendocrine and immunological causes of RMD. Best results in the control of the pain are obtained by the strict cooperation between the rheumatologists and the patients, with the support of the
health professionals. The European league against rheumatic diseases (EULAR) is engaged in several initiatives to optimise pain control and several recommendations have been published. In addition, since pain has a circadian rhythm, with highest levels during the night, the chronotherapy of the inflammatory reaction with drugs acting during the night has been found more successful.
Actually Prof. Maurizio Cutolo, M.D. is professor of Rheumatology and Internal Medicine; he serves as Director of the Research Laboratories, Clinical Academic Division of Rheumatology and of the Academic Postgraduate School of Rheumatology at the University of Genova. Prof. M Cutolo is co-chair of the European (EU) ERN network ReCONNECT on Rare Connective Tissue Diseases. M Cutolo is PI in a national site, for an HORIZON 2020 project (2015-2019). He is Past EULAR President and Past Chairman of the International Society of Rheumatology (ILAR). He has been Advisory Editor of the Journal Arthritis & Rheumatism and actually is Associate Editor of the Journal Clinical and Exp. Rheumatology. He was the Vice President of the Italian Society for Rheumatology and also Vice President of the International Society for Neuro immuno modulation (ISNIM). M Cutolo Co-founded in 1999 and he was the Chairman of the Study Group on Neuro Endocrine Immunology (NEI) at the American College of Rheumatology. M Cutolo is chairman of the Study Group on Capillaroscopy and RMD at ACR. He served as a Member of the Scientific Committee of EULAR from 2004 to 2007 and Executive Committee until now (2017). M Cutolo published 500 peer reviewed papers (Pub Med). M Cutolo is expert on management of chronic RMD with the use of glucocorticoids (GCs), biologicals, biosimilars. disease modifying anti inflammatory drugs (DMARDs), non steroidal anti-inflammatory drugs (NSAIDs). M Cutolo has started the fearly studies about the chronotherapy of RMDs and the endocrine extrabone activities of Vitamin D.